Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 3
2019 1
2020 2
2021 4
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
NF-kB and the CLL microenvironment.
O'Donnell A, Pepper C, Mitchell S, Pepper A. O'Donnell A, et al. Among authors: pepper a. Front Oncol. 2023 Mar 30;13:1169397. doi: 10.3389/fonc.2023.1169397. eCollection 2023. Front Oncol. 2023. PMID: 37064123 Free PMC article. Review.
Allogeneic CAR-T Cells: More than Ease of Access?
Graham C, Jozwik A, Pepper A, Benjamin R. Graham C, et al. Among authors: pepper a. Cells. 2018 Oct 1;7(10):155. doi: 10.3390/cells7100155. Cells. 2018. PMID: 30275435 Free PMC article. Review.
Computational modeling of DLBCL predicts response to BH3-mimetics.
Cloete I, Smith VM, Jackson RA, Pepper A, Pepper C, Vogler M, Dyer MJS, Mitchell S. Cloete I, et al. Among authors: pepper a. NPJ Syst Biol Appl. 2023 Jun 6;9(1):23. doi: 10.1038/s41540-023-00286-5. NPJ Syst Biol Appl. 2023. PMID: 37280330 Free PMC article.
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies.
Pepper AGS, Zucchetto A, Norris K, Tissino E, Polesel J, Soe Z, Allsup D, Hockaday A, Ow PL, Hillmen P, Rawstron A, Catovsky D, Bulian P, Bomben R, Baird DM, Fegan CD, Gattei V, Pepper C. Pepper AGS, et al. Leukemia. 2022 Jan;36(1):271-274. doi: 10.1038/s41375-021-01322-1. Epub 2021 Jun 19. Leukemia. 2022. PMID: 34148055 Free PMC article. No abstract available.
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.
Kennedy E, Coulter E, Halliwell E, Profitos-Peleja N, Walsby E, Clark B, Phillips EH, Burley TA, Mitchell S, Devereux S, Fegan CD, Jones CI, Johnston R, Chevassut T, Schulz R, Seiffert M, Agathanggelou A, Oldreive C, Davies N, Stankovic T, Liloglou T, Pepper C, Pepper AGS. Kennedy E, et al. Among authors: pepper ags. Blood. 2021 Jun 3;137(22):3064-3078. doi: 10.1182/blood.2020005964. Blood. 2021. PMID: 33512408 Free PMC article.
15 results